-
LRG1, Neutrophil Mitochondria, and Bladder Cancer
2026-09-30
This 2026 Advanced Science study identifies a tumor-derived LRG1–ANXA2 pathway that disrupts neutrophil mitochondrial homeostasis, promotes NET formation, and destabilizes bladder cancer vasculature. Its findings connect mitochondrial stress in innate immune cells with vascular dysfunction, impaired therapy delivery, and resistance to cisplatin and anti-PD-1 treatment.
-
Dihydroethidium for Live-Cell Superoxide Assays
2026-09-30
Dihydroethidium, also called hydroethidine, converts superoxide-associated redox changes into a live-cell fluorescence readout that can be integrated with mitochondrial and injury endpoints. This practical guide shows how to build an oxidative stress assay around DHE, interpret results in renal ischemia–reperfusion models, and avoid common selectivity, loading, and normalization errors.
-
LNP-miR-200c Blocks Pancreatic Cancer Growth and Migration
2026-09-29
Yu et al. show that miR-200c suppresses pancreatic cancer through two complementary routes: nuclear activation of PTPN6 transcription through an enhancer and post-transcriptional repression of CDH17. LNP delivery strengthened the anti-tumor effect in vivo, while the study’s mechanistic framework separates proliferation control from migration control.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-09-29
The reference study identifies ALDOB K87 lactylation as a metabolic–mitochondrial switch that connects hypoxia-driven glycolysis to DRP1-dependent mitochondrial fission in pulmonary hypertension. Its integrated lactylomic, cellular, and animal experiments position the lactate–ALDOB–DRP1 axis as a mechanistic framework for interpreting pulmonary vascular remodeling.
-
Tamoxifen Workflows for Gene Knockout and Cancer Models
2026-09-28
Tamoxifen combines temporal CreER control with clinically relevant estrogen-receptor pharmacology, making it useful across conditional genetics, breast cancer research, and mechanistic oncology assays. This guide connects practical formulation, induction, mitochondrial iron readouts, and troubleshooting to findings from a recent PINK1-deficiency study.
-
Gepotidacin (GSK2140944): Topoisomerase Research
2026-09-28
Gepotidacin offers translational researchers a way to examine bacterial type II topoisomerase inhibition through a distinct binding mechanism, connect target engagement with antibacterial phenotypes, and design resistance-aware experiments.
-
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
2026-09-27
A practical guide to interpreting dual fluorescence and luciferase readouts in cell-based assays. Learn how SKU R1010 can help distinguish mRNA delivery from reporter expression, and how to handle and evaluate it without overinterpreting the signal.
-
From SERPINH1 Signaling to S-Phase Evidence
2026-09-26
A mechanistic study links SERPINH1, MMP-9, TGF-β1, and fibroblast activation in lung adenocarcinoma. This article examines how EdU-based S-phase measurements can strengthen follow-up experiments—and where that readout must be interpreted alongside other evidence.
-
β-Amanitin Workflows for Transcription Research
2026-09-25
Use β-Amanitin to probe RNA polymerase II-dependent transcription with a controlled, vehicle-matched workflow—not as a stand-in for a validated mushroom-toxin test. The article also explains how recent dual-target amatoxin and phallotoxin biosensing results can inform assay selection while keeping mechanistic experiments and food-safety detection distinct.
-
PKM2 Inhibition: From Tumor Metabolism to Translation
2026-09-25
PKM2 inhibition offers a way to interrogate cancer-cell metabolism, but translational value depends on context. We connect compound 3k’s reported cancer-model data with new evidence on PKM2-dependent macrophage reprogramming—and outline how researchers can test the distinction rigorously.
-
Mouse Neutrophil Cell Isolation Kit for Tumor Immunology
2026-09-24
Connect tumor-immunology questions to functional mouse neutrophil assays with a rapid, column-free negative-selection workflow. The kit is designed to enrich neutrophils without directly labeling the target cells, helping researchers preserve cells for downstream phenotyping and functional studies.
-
Selective Spectrophotometry of Phenolic β-Lactams
2026-09-24
Salem and Saleh developed two acid-mediated spectrophotometric methods that use cerium(IV) or iron(III) oxidation to quantify four phenolic β-lactam antibiotics through a yellow product measured at 397 nm. The reported linear ranges, recoveries, and formulation tests support their potential for routine quality-control analysis, while the study does not establish a direct assay for dicloxacillin itself.
-
SM-102 Beyond Vaccines: Local mRNA Therapy
2026-09-23
SM-102 is best understood not only as an mRNA vaccine lipid but as a formulation component whose performance depends on the delivery route and biological question. A recent bladder-cancer study offers a distinct case study in local mRNA therapy—and practical lessons for designing assays that separate delivery, expression, and therapeutic effect.
-
Azilsartan Medoxomil Monopotassium Workflow
2026-09-23
Build concentration-controlled AT1 receptor assays and translational hypertension models with Azilsartan medoxomil monopotassium, also known as TAK 491. This workflow connects sustained receptor blockade with 24-hour blood pressure readouts, cardiovascular disease research, and practical troubleshooting from stock preparation through in vivo dosing.
-
EdU Imaging Kits (Cy5) for Causal S-Phase Studies
2026-09-22
EdU Imaging Kits (Cy5) provide direct S-phase DNA synthesis data for mechanistic studies of endothelial remodeling. This guide shows how to use the K1076 workflow to interpret hypoxia- and EGLN3-linked proliferation without confusing DNA replication with completed cell division.